SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-114920
Filing Date
2021-04-14
Accepted
2021-04-13 19:08:02
Documents
16
Period of Report
2021-04-10
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d148084d8k.htm   iXBRL 8-K 26829
2 EX-99.1 d148084dex991.htm EX-99.1 11270
3 EX-99.2 d148084dex992.htm EX-99.2 13533
7 GRAPHIC g148084g0414013148934.jpg GRAPHIC 3812
8 GRAPHIC g148084page006.jpg GRAPHIC 302555
  Complete submission text file 0001193125-21-114920.txt   611363

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA fstx-20210410.xsd EX-101.SCH 2733
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE fstx-20210410_lab.xml EX-101.LAB 18702
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fstx-20210410_pre.xml EX-101.PRE 11778
9 EXTRACTED XBRL INSTANCE DOCUMENT d148084d8k_htm.xml XML 3553
Mailing Address 35 PARKWOOD DRIVE BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT
Business Address 35 PARKWOOD DRIVE BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT 44 1223 497400
F-star Therapeutics, Inc. (Filer) CIK: 0001566373 (see all company filings)

IRS No.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37718 | Film No.: 21824219
SIC: 2834 Pharmaceutical Preparations